文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一种基于尿液的替诺福韦依从性检测方法在肯尼亚用于监测和提供关于暴露前预防(PrEP)依从性反馈的可接受性和可行性。

Acceptability and feasibility of a urine-based tenofovir adherence assay for monitoring and providing feedback on PrEP adherence in Kenya.

作者信息

Okello Phelix, Velloza Jennifer, Ogello Vallery, Owidi Emmah, Mogere Peter, Gakuo Stephen, Chakravarty Deepalika, Biwott Charlene, Chatterjee Purba, Mugo Nelly, Gandhi Monica, Ngure Kenneth

机构信息

Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.

Department of Medicine, University of California, San Franscisco (UCSF), San Franscisco, CA, USA.

出版信息

AIDS Care. 2025 Feb;37(2):324-336. doi: 10.1080/09540121.2024.2444556. Epub 2024 Dec 28.


DOI:10.1080/09540121.2024.2444556
PMID:39733245
Abstract

Objective measures of oral PrEP adherence - especially point-of-care (POC) measures that enable real-time assessment, intervention, and feedback - have the potential to improve adherence. Our team previously developed and validated a novel urine-based POC metric of PrEP adherence. In this study, we sought to determine whether this assay is acceptable and feasible among women taking PrEP and PrEP providers in Kenya. We conducted a trial comparing PrEP adherence counseling using the assay (intervention) versus standard-of-care counseling. We conducted in-depth interviews (IDIs) with intervention-arm participants (n = 20), and focus group discussions (n = 18) after the final (12-month) follow-up visit. We also conducted IDIs with purposively-sampled healthcare providers (HCPs) (n = 8) who administered the assay. The assay was highly acceptable among participants and HCPs as it was perceived to be accurate, could provide evidence of adherence, provides real-time results, and improves participant and provider relationship. HCPs reported that the assay facilitated counseling, seemed to increase adherence, and would be feasible to implement in routine care settings. Both participants and HCPs reported concerns about the assay related to the fear of being stigmatized for negative results, and test accessibility. Future studies should evaluate the impact of this novel test on adherence patterns over time in diverse populations.Trial registration: ClinicalTrials.gov identifier: NCT03935464.

摘要

口服暴露前预防(PrEP)依从性的客观测量方法——尤其是能够实现实时评估、干预和反馈的即时检测(POC)方法——有可能提高依从性。我们的团队之前开发并验证了一种基于尿液的新型PrEP依从性即时检测指标。在本研究中,我们试图确定该检测方法在肯尼亚服用PrEP的女性和PrEP提供者中是否可接受且可行。我们进行了一项试验,比较使用该检测方法的PrEP依从性咨询(干预组)与标准护理咨询。在最后一次(12个月)随访后,我们对干预组参与者(n = 20)进行了深入访谈(IDI),并进行了焦点小组讨论(n = 18)。我们还对有意抽样的实施该检测的医疗保健提供者(HCP)(n = 8)进行了IDI。该检测方法在参与者和HCP中高度可接受,因为他们认为其准确、能够提供依从性证据、能提供实时结果,并且改善了参与者与提供者之间的关系。HCP报告称该检测方法有助于咨询,似乎能提高依从性,并且在常规护理环境中实施是可行的。参与者和HCP都报告了对该检测方法的担忧,包括担心因检测结果为阴性而受到污名化以及检测的可及性。未来的研究应评估这种新型检测方法随时间推移对不同人群依从模式的影响。试验注册:ClinicalTrials.gov标识符:NCT03935464。

相似文献

[1]
Acceptability and feasibility of a urine-based tenofovir adherence assay for monitoring and providing feedback on PrEP adherence in Kenya.

AIDS Care. 2025-2

[2]
Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial.

JMIR Res Protoc. 2020-4-2

[3]
High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort.

J Int AIDS Soc. 2024-12

[4]
High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.

PLoS Med. 2023-2

[5]
Evaluation of the Tu'Washindi Na PrEP Intervention to Reduce Gender-Based Violence and Increase Preexposure Prophylaxis Uptake and Adherence Among Kenyan Adolescent Girls and Young Women: Protocol for a Cluster Randomized Controlled Trial.

JMIR Res Protoc. 2025-4-1

[6]
Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.

Lancet HIV. 2016-11-18

[7]
Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator-Delivered Integrated Prevention Package (HPTN 112-NJIRA Study).

JMIR Res Protoc. 2025-6-18

[8]
Development of a Clinic-Based, Sociostructural Intervention to Improve the Provision of Pre-Exposure Prophylaxis for Cisgender Women: Formative Study Using the Assessment, Decision, Adaptation, Production, Topical Experts, Integration, Training, and Testing (ADAPT-ITT) Framework.

JMIR Form Res. 2025-8-6

[9]
High acceptability, feasibility and sustainability of a direct-to-pharmacy differentiated PrEP delivery model in public health HIV clinics in Kenya: perspectives of PrEP clients and healthcare providers.

J Int AIDS Soc. 2025-7

[10]
Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.

BMC Health Serv Res. 2024-5-11

本文引用的文献

[1]
Population size, HIV prevalence, and antiretroviral therapy coverage among key populations in sub-Saharan Africa: collation and synthesis of survey data, 2010-23.

Lancet Glob Health. 2024-9

[2]
Impact of a point-of-care urine tenofovir assay on adherence to HIV pre-exposure prophylaxis among women in Kenya: a randomised pilot trial.

Lancet HIV. 2024-8

[3]
Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots: Results from a Pilot Study Among Patients and Providers in Cape Town, South Africa.

AIDS Behav. 2023-10

[4]
Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability.

AIDS Care. 2023-10

[5]
Feasibility and acceptability of using the novel urine-based FujiLAM test to detect tuberculosis: A multi-country mixed-methods study.

J Clin Tuberc Other Mycobact Dis. 2022-4-25

[6]
Point-of-Care Test for Assessing Tenofovir Adherence: Feasibility and Recommendations from Women in an Oral PrEP Program in Kenya and Their Healthcare Providers.

AIDS Behav. 2021-11

[7]
"I Just Decided to Stop:" Understanding PrEP Discontinuation Among Individuals Initiating PrEP in HIV Care Centers in Kenya.

J Acquir Immune Defic Syndr. 2021-5-1

[8]
Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.

AIDS Res Ther. 2020-8-6

[9]
Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial.

JMIR Res Protoc. 2020-4-2

[10]
Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings.

AIDS. 2020-2-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索